Literature DB >> 15967881

Relationship of technetium Tc 99m sestamibi scans to histopathological features of hyperfunctioning parathyroid tissue.

Nicholas Y Mehta1, James M Ruda, Silloo Kapadia, Phillip J Boyer, Christopher S Hollenbeak, Brendan C Stack.   

Abstract

OBJECTIVE: To investigate the histopathological features of pathologic parathyroid specimens associated with negative preoperative technetium Tc 99m sestamibi scans.
DESIGN: Retrospective study.
SETTING: Tertiary care center. PATIENTS: One hundred fourteen patients who underwent sestamibi scans before surgical exploration for primary hyperparathyroidism between 1996 and 2001.
INTERVENTIONS: Surgical exploration and removal of parathyroid adenomas. MAIN OUTCOME MEASURES: Histopathological characteristics associated with true-positive and false-negative sestamibi scans, including parathyroid specimen weight, size, relative oxyphil and chief cell content, parathyroid hormone staining patterns, cellular architecture, and various immunohistochemical staining patterns.
RESULTS: Twenty-three (24%) of 98 patients with parathyroid adenomas had negative sestamibi scan results. Among 20 age- and sex-matched patients with false-negative results vs 20 patients with true-positive results, tumor size (P = .04) and oxyphil cell content (P = .03) were found to be significantly different.
CONCLUSION: Parathyroid gland size and oxyphil content are descriptive and predict differences between sestamibi properties of parathyroid adenomas but have no current therapeutic implications for parathyroid surgery.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15967881     DOI: 10.1001/archotol.131.6.493

Source DB:  PubMed          Journal:  Arch Otolaryngol Head Neck Surg        ISSN: 0886-4470


  13 in total

Review 1.  How to localize parathyroid tumors in primary hyperparathyroidism?

Authors:  T Uruno; E Kebebew
Journal:  J Endocrinol Invest       Date:  2006-10       Impact factor: 4.256

2.  Sestamibi SPECT intensity scoring system in sporadic primary hyperparathyroidism.

Authors:  Linwah Yip; Daniel A Pryma; John H Yim; Sally E Carty; Jennifer B Ogilvie
Journal:  World J Surg       Date:  2009-03       Impact factor: 3.352

Review 3.  Imaging for primary hyperparathyroidism--an evidence-based analysis.

Authors:  Radu Mihai; Dietmar Simon; Per Hellman
Journal:  Langenbecks Arch Surg       Date:  2009-07-10       Impact factor: 3.445

4.  Proteomics Analysis of Tissue Samples Reveals Changes in Mitochondrial Protein Levels in Parathyroid Hyperplasia over Adenoma.

Authors:  Gurler Akpinar; Murat Kasap; Nuh Zafer Canturk; Mehin Zulfigarova; Eylül Ece Islek; Sertac Ata Guler; Turgay Simsek; Zeynep Canturk
Journal:  Cancer Genomics Proteomics       Date:  2017 May-Jun       Impact factor: 4.069

5.  Negative imaging studies for primary hyperparathyroidism are unavoidable: correlation of sestamibi and high-resolution ultrasound scanning with histological analysis in 150 patients.

Authors:  Radu Mihai; Fergus Gleeson; Ian D Buley; Derek E Roskell; Gregory P Sadler
Journal:  World J Surg       Date:  2006-05       Impact factor: 3.352

6.  Personalized nuclear imaging protocol in cases with nodular goiter and parathyroid adenoma.

Authors:  W Jalloul; R Tibu; T M Ionescu; C R Stolniceanu; I Grierosu; A Tarca; L Ionescu; M C Ungureanu; D Ciobanu; V Ghizdovat; C Stefanescu
Journal:  Acta Endocrinol (Buchar)       Date:  2021 Jul-Sep       Impact factor: 0.877

Review 7.  Minimally invasive parathyroidectomy: benefits and requirements of localization, diagnosis, and intraoperative PTH monitoring. long-term results.

Authors:  Douglas L Fraker; Hasly Harsono; Robert Lewis
Journal:  World J Surg       Date:  2009-11       Impact factor: 3.352

8.  Impact of adenoma weight and ectopic location of parathyroid adenoma on localization study results.

Authors:  Yeşim Erbil; Umut Barbaros; Mustafa Tükenmez; Halim Işsever; Artür Salmaslioğlu; Işik Adalet; Selçuk Ozarmağan; Serdar Tezelman
Journal:  World J Surg       Date:  2008-04       Impact factor: 3.352

Review 9.  Parathyroid nuclear scan. A focused review on the technical and biological factors affecting its outcome.

Authors:  Subramanian Kannan; Mira Milas; Donald Neumann; Rikesh T Parikh; Alan Siperstein; Angelo Licata
Journal:  Clin Cases Miner Bone Metab       Date:  2014-01

10.  Can a lightbulb sestamibi SPECT accurately predict single-gland disease in sporadic primary hyperparathyroidism?

Authors:  Linwah Yip; Daniel A Pryma; John H Yim; Mohamed A Virji; Sally E Carty; Jennifer B Ogilvie
Journal:  World J Surg       Date:  2008-05       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.